Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas

BRCA1/2-mutated ovarian cancers (OCs) are defective in homologous recombination repair (HRR) of double-strand breaks (DSBs) and thereby sensitive to platinum and PARP inhibitors (PARPis). Multiple PARPis have recently received US Food and Drug Administration (FDA) approval for treatment of OCs, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Rep
Autors principals: Meghani, Khyati, Fuchs, Walker, Detappe, Alexandre, Drané, Pascal, Gogola, Ewa, Rottenberg, Sven, Jonkers, Jos, Matulonis, Ursula, Swisher, Elizabeth M., Konstantinopoulos, Panagiotis A., Chowdhury, Dipanjan
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5908239/
https://ncbi.nlm.nih.gov/pubmed/29617652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2018.03.038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars